Liu_2020_Chin.J.Integr.Med_26_577

Reference

Title : Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial - Liu_2020_Chin.J.Integr.Med_26_577
Author(s) : Liu NY , Pei H , Liu MX , Liu LT , Fu CG , Li H , Chen KJ
Ref : Chin J Integr Med , 26 :577 , 2020
Abstract : Liu_2020_Chin.J.Integr.Med_26_577
ESTHER : Liu_2020_Chin.J.Integr.Med_26_577
PubMedSearch : Liu_2020_Chin.J.Integr.Med_26_577
PubMedID: 32761337

Related information

Citations formats

Liu NY, Pei H, Liu MX, Liu LT, Fu CG, Li H, Chen KJ (2020)
Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial
Chin J Integr Med 26 :577

Liu NY, Pei H, Liu MX, Liu LT, Fu CG, Li H, Chen KJ (2020)
Chin J Integr Med 26 :577